Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
Kanatani A, Nakagawa T, Kawai T, Naito A, Sato Y, Yoshida K, Nozaki K, Nagata M, Yamada Y, Azuma T, Suzuki M, Fujimura T, Fukuhara H, Nishimatsu H, Kume H, Igawa Y, Homma Y. Kanatani A, et al. Among authors: igawa y. Clin Genitourin Cancer. 2015 Apr;13(2):e107-12. doi: 10.1016/j.clgc.2014.09.007. Epub 2014 Nov 6. Clin Genitourin Cancer. 2015. PMID: 25456839
Defining overactive bladder as hypersensitivity.
Yamaguchi O, Honda K, Nomiya M, Shishido K, Kakizaki H, Tanaka H, Yamanishi T, Homma Y, Takeda M, Araki I, Obara K, Nishizawa O, Igawa Y, Goto M, Yokoyama O, Seki N, Takei M, Yoshida M. Yamaguchi O, et al. Among authors: igawa y. Neurourol Urodyn. 2007 Oct;26(6 Suppl):904-7. doi: 10.1002/nau.20482. Neurourol Urodyn. 2007. PMID: 17663416 Review.
Clinical guidelines for overactive bladder.
Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, Obara K, Gotoh M, Igawa Y, Seki N, Yoshida M; Neurogenic Bladder Society. Yamaguchi O, et al. Among authors: igawa y. Int J Urol. 2009 Feb;16(2):126-42. doi: 10.1111/j.1442-2042.2008.02177.x. Int J Urol. 2009. PMID: 19228224 No abstract available.
Clinical guideline for male lower urinary tract symptoms.
Homma Y, Araki I, Igawa Y, Ozono S, Gotoh M, Yamanishi T, Yokoyama O, Yoshida M; Japanese Society of Neurogenic Bladder. Homma Y, et al. Among authors: igawa y. Int J Urol. 2009 Oct;16(10):775-90. doi: 10.1111/j.1442-2042.2009.02369.x. Int J Urol. 2009. PMID: 19811547
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.
Takeda M, Homma Y, Araki I, Kakizaki H, Yamanishi T, Yokota T, Gotoh M, Igawa Y, Seki N, Takei M, Yoshida M, Sugaya K, Nishizawa O; Japanese Naftopidil Neurogenic Lower Urinary Tract Dysfunction Study Group. Takeda M, et al. Among authors: igawa y. BJU Int. 2011 Jul;108(1):100-7. doi: 10.1111/j.1464-410X.2010.09682.x. Epub 2010 Nov 9. BJU Int. 2011. PMID: 21062392 Clinical Trial.
Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires.
Nakamura M, Fujimura T, Nagata M, Hosoda C, Suzuki M, Fukuhara H, Enomoto Y, Nishimatsu H, Kume H, Igawa Y, Homma Y. Nakamura M, et al. Among authors: igawa y. Aging Male. 2012 Jun;15(2):111-4. doi: 10.3109/13685538.2011.646342. Epub 2012 Jan 30. Aging Male. 2012. PMID: 22283118 Free article.
260 results